Canine ASCT1 and ASCT2 are functional receptors for RD-114 virus in dogs

Journal of General Virology

Volumn 93, Issue 3, 2012, Pages 603-607

  Yoshikawa, Rokusuke ^a,b   Yasuda, Jiro ^c   Kobayashi, Takeshi ^a   Miyazawa, Takayuki ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; ASCT1 PROTEIN; ASCT2 PROTEIN; UNCLASSIFIED DRUG; VACCINE; VIRUS RECEPTOR;

ARTICLE; CELL LINE; CELL PROLIFERATION; DOG; HUMAN; IMMUNE DEFICIENCY; KIDNEY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RD 114 VIRUS; RETROVIRUS; VIRAL CONTAMINATION;

AMINO ACID TRANSPORT SYSTEM ASC; ANIMALS; CELLS, CULTURED; DOGS; ENDOGENOUS RETROVIRUSES; MASON-PFIZER MONKEY VIRUS; RECEPTORS, VIRUS; VIRUS ATTACHMENT;

CANIS FAMILIARIS; FELIS CATUS; MACACA MULATTA; SIMIAN RETROVIRUS 2;

EID: 84863116173     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.036228-0     Document Type: Article

References (32)

1. Arriza, J. L., Kavanaugh, M. P., Fairman, W. A., Wu, Y. N., Murdoch, G. H., North, R. A. & Amara, S. G. (1993). Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family. J Biol Chem 268, 15329- 15332.
2. Baumann, J. G., Günzburg, W. H. & Salmons, B. (1998). CrFK feline kidney cells produce an RD114-like endogenous virus that can package murine leukemia virus-based vectors. J Virol 72, 7685-7687.
3. Blaise, S., Mangeney, M. & Heidmann, T. (2001). The envelope of Mason-Pfizer monkey virus has immunosuppressive properties. J Gen Virol 82, 1597-1600.
4. Cianciolo, G. J., Copeland, T. D., Oroszlan, S. & Snyderman, R. (1985). Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230, 453-455.
5. Cosset, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A. & Collins, M. K. (1995). High-titer packaging cells producing recombinant retro-viruses resistant to human serum. J Virol 69, 7430-7436.
6. Fischinger, P. J., Peebles, P. T., Nomura, S. & Haapala, D. K. (1973). Isolation of RD-114-like oncornavirus from a cat cell line. J Virol 11, 978-985.
7. Green, B. J., Lee, C. S. & Rasko, J. E. J. (2004). Biodistribution of the RD114/mammalian type D retrovirus receptor, RDR. J Gene Med 6, 249-259.
8. Marin, M., Tailor, C. S., Nouri, A. & Kabat, D. (2000). Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus. J Virol 74, 8085-8093.
9. Marin, M., Lavillette, D., Kelly, S. M. & Kabat, D. (2003). N-Linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions. J Virol 77, 2936-2945.
10. Marx, P. A., Maul, D. H., Osborn, K. G., Lerche, N. W., Moody, P., Lowenstine, L. J., Henrickson, R. V., Arthur, L. O., Gilden, R. V. & other authors (1984). Simian AIDS: isolation of a type D retrovirus and transmission of the disease. Science 223, 1083-1086.
11. Marx, P. A., Bryant, M. L., Osborn, K. G., Maul, D. H., Lerche, N. W., Lowenstine, L. J., Kluge, J. D., Zaiss, C. P., Henrickson, R. V. & other authors (1985). Isolation of a new serotype of simian acquired immune deficiency syndrome type D retrovirus from Celebes black macaques (Macaca nigra) with immune deficiency and retroperito-neal fibromatosis. J Virol 56, 571-578.
12. Miyazawa, T., Yoshikawa, R., Golder, M., Okada, M., Stewart, H. & Palmarini, M. (2010). Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets. J Virol 84, 3690- 3694.
13. Montiel, N. A. (2010). An updated review of simian betaretrovirus (SRV) in macaque hosts. J Med Primatol 39, 303-314.
14. Narushima, R., Usui, T., Ogawa, T. & Shimazaki, T. (2010). Detection of infectious RD114 virus in feline live multivalent vaccines and provisional safety evaluation in cats. J Jpn Vet Med Assoc 63, 630-633. (in Japanese with English summary).
15. Narushima, R., Horiuchi, N., Usui, T., Ogawa, T., Takahashi, T. & Shimazaki, T. (2011a). Experimental infection of dogs with a feline endogenous retrovirus RD-114. Acta Vet Scand 53, 3.
16. Narushima, R., Shimazaki, T. & Takahashi, T. (2011b). Development of a real-time reverse-transcription-PCR method for detection of RD114 virus in canine vaccines. Biologicals 39, 89-93.
17. Okabe, H., Gilden, R. V. & Hatanaka, M. (1973). RD 114 virus-specific sequences in feline cellular RNA: detection and characterization. J Virol 12, 984-994.
18. Okada, M., Yoshikawa, R., Shojima, T., Baba, K. & Miyazawa, T. (2011). Susceptibility and production of a feline endogenous retro-virus (RD-114 virus) in various feline cell lines. Virus Res 155, 268-273.
19. Rasko, J. E., Battini, J. L., Gottschalk, R. J., Mazo, I. & Miller, A. D. (1999). The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci U S A 96, 2129-2134.
20. Roth, M. G., Srinivas, R. V. & Compans, R. W. (1983). Basolateral maturation of retroviruses in polarized epithelial cells. J Virol 45, 1065-1073.
21. Sakaguchi, S., Baba, K., Ishikawa, M., Yoshikawa, R., Shojima, T. & Miyazawa, T. (2008a). Focus assay on RD114 virus in QN10S cells. J Vet Med Sci 70, 1383-1386.
22. Sakaguchi, S., Okada, M., Shojima, T., Baba, K. & Miyazawa, T. (2008b). Establishment of a LacZ marker rescue assay to detect infectious RD114 virus. J Vet Med Sci 70, 785-790.
23. Stratton, M. R., Darling, J., Pilkington, G. J., Lantos, P. L., Reeves, B. R. & Cooper, C. S. (1989). Characterization of the human cell line TE671. Carcinogenesis 10, 899-905.
24. Tailor, C. S., Nouri, A., Zhao, Y., Takeuchi, Y. & Kabat, D. (1999). A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J Virol 73, 4470-4474.
25. Takeuchi, Y., Simpson, G., Vile, R. G., Weiss, R. A. & Collins, M. K. (1992). Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses. Virology 186, 792-794.
26. Takeuchi, Y., Cosset, F.-L. C., Lachmann, P. J., Okada, H., Weiss, R. A. & Collins, M. K. L. (1994). Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 68, 8001-8007.
27. Takeuchi, Y., Porter, C. D., Strahan, K. M., Preece, A. F., Gustafsson, K., Cosset, F.-L., Weiss, R. A. & Collins, M. K. L. (1996). Sensitization of cells and retroviruses to human serum by (a1-3) galactosyltransferase. Nature 379, 85-88.
28. De Ravin, S. S. T., Kennedy, D. R., Naumann, N., Kennedy, J. S., Choi, U., Hartnett, B. J., Linton, G. F., Whiting-Theobald, N. L., Moore, P. F. & other authors (2006). Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy. Blood 107, 3091-3097.
29. +-dependent neutral amino acid transporter. J Biol Chem 271, 14883-14890.
30. Yoshikawa, R., Sato, E., Igarashi, T. & Miyazawa, T. (2010). Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cells. J Clin Microbiol 48, 3366- 3369.
31. Yoshikawa, R., Sato, E. & Miyazawa, T. (2011a). Contamination of infectious RD-114 virus in vaccines produced using non-feline cell lines. Biologicals 39, 33-37.
32. Yoshikawa, R., Sato, E. & Miyazawa, T. (2011b). Presence of infectious RD-114 virus in a proportion of canine parvovirus isolates. J Vet Med Sci (in press). http://dx.doi.org/10.1292/jvms.11-0219